Psychiatry Medical News about Antipsychotic Agents

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Omega-3 fatty acids for bipolar disorder

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Psychopharmacology and adverse effects of antipsychotic long-acting injections: a review
British Journal of Psychiatry, 11/09/09

Taylor D et al. – Dosing of LAIs is complicated by delayed release of drug, changes in plasma levels without change in dose, and by the lack of data establishing clear dose requirements. All LAIs offer the prospect of assured adherence (although patients may still default on treatment) but their use is complicated by adverse effects, complex pharmacokinetics and confusion over dose–response relationships.

<< Previous
Changes in metabolic syndrome parameters in patients with...

Next >>
Social skills and neurocognitive individualized training in...

Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia
Neuropsychiatric Disease and Treatment, 10/02/09 Relevance Score: 68%

Genomewide Association Study of Movement-Related Adverse Antipsychotic Effects
Biological Psychiatry, 11/05/09 Relevance Score: 66%

Apolipoprotein-E gene variants associated with cardiovascular risk factors in antipsychotic recipients
European Psychiatry, 11/06/09 Relevance Score: 65%

Metabolic and Cardiac Side Effects of Second-generation Antipsychotics: What Every Clinician Should Know
Journal of Pharmacy Practice, 11/05/09 Relevance Score: 65%

Junior doctors' knowledge and practice of electrocardiographic monitoring for high-risk patients receiving antipsychotic medications
Psychiatric Bulletin, 10/05/09 Relevance Score: 65%